
Cellares
The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.
About
Cellares is the first Integrated Development and Manufacturing Organization (IDMO) for cell therapy. They offer end-to-end manufacturing services and proprietary technologies like the Cell Shuttle® and Cell Q™ to accelerate access to life-saving cell therapies. Cellares serves companies developing cell therapies by providing manufacturing excellence at scale across a global network of Smart Factories. Teams look it up for Biotechnology, Pharmaceuticals, Healthcare.
Frequently asked
What does Cellares do?
Cellares is a Biotechnology company that offers Services. Teams look it up for Pharmaceuticals, Healthcare, Life Sciences. It is based in South San Francisco, California, USA and was founded in 2019. Public records show $327M in total funding. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Cellares raised?
Cellares has raised a total of $327M in funding. The most recent round on record is Funding Round.
Where is Cellares headquartered?
Cellares is headquartered in South San Francisco, California, USA.
When was Cellares founded?
Cellares was founded in 2019.
What industry does Cellares operate in?
Cellares operates in Biotechnology, Pharmaceuticals, Healthcare, Life Sciences, Biotech.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.
“Does anyone have any information about working at Cellares? Pros? Cons? Anything to know for potential employees? Company outlook?”
View on Reddit“I'm very interested in how automation is being used in T cell engineering/cell therapy manufacturing and i was wondering what you guys thought about companies like cellares or multiply labs and their future in the market, especially given h…”
View on Reddit“Cellares received cGMP certification of their new factory-in-a-box platform that can automate a huge portion of the production of targeted cell therapies. The company claims the system being able to reduce cost by up to 50% and failures by…”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.
